MMV in partnership: the Eurartesim® experience
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Link
http://link.springer.com/content/pdf/10.1186/1475-2875-12-211.pdf
Reference39 articles.
1. Nayyar GM, Breman JG, Newton PN, Herrington J: Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet Infect Dis. 2012, 12: 488-496. 10.1016/S1473-3099(12)70064-6.
2. WHO: Antimalarial drug combination therapy: report of a WHO technicalconsultation. 2001, Geneva: World Health Organization,
3. Denis MB, Davis TME, Hewitt S, Incardona S, Nimol K, Fandeur T, Poravuth Y, Lim C, Socheat D: Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodianchildren and adults with uncomplicated falciparum malaria. Clin Infect Dis. 2002, 35: 1469-1476. 10.1086/344647.
4. Karunajeewa H, Lim C, Hung T-Y, Ilett KF, Denis MB, Socheat D, Davis TME: Safety evaluation of fixed combination piperaquine plus dihydroartemisinin(Artekin®) in Cambodian children and adults withmalaria. Br J Clin Pharmacol. 2003, 57: 93-99. 10.1046/j.1365-2125.2003.01962.x.
5. Ashley EA, Krudsood S, Phaiphun L, Srivilairit S, McGready R, Leowattana W, Hutagalung W, Wilairatana P, Brockman A, Looareesuwan S, Nosten F, White NJ: Randomized, controlled dose-optimization studies ofdihydroartemisinin-piperaquine for the treatment of uncomplicatedmultidrug-resistant falciparum malaria in Thailand. J Infect Dis. 2004, 190: 1773-1782. 10.1086/425015.
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A high-throughput LC-MS/MS assay for piperaquine from dried blood spots: Improving malaria treatment in resource-limited settings;Journal of Mass Spectrometry and Advances in the Clinical Lab;2024-01
2. Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion;Malaria Journal;2023-09-06
3. Expert perspectives on the introduction of Triple Artemisinin-based Combination Therapies (TACTs) in Southeast Asia: a Delphi study;BMC Public Health;2022-04-30
4. Impact of the European Union on access to medicines in low- and middle-income countries: A scoping review;The Lancet Regional Health - Europe;2021-10
5. Market Formation in a Global Health Transition;Environmental Innovation and Societal Transitions;2021-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3